Search clinical trials for: neuroendocrine carcinoma

Total 32933 results

Wills Eye

Completed

Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema

Melanoma

United States
Pacira Pharmaceuticals, Inc

Completed

DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor

Meningeal Neoplasms

United States, Canada
Oncology Institute of Southern Switzerland

Completed

OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation

Differentiated Thyroid Carcinoma
YM BioSciences

Terminated

DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer

Breast Cancer | Metastases

United Kingdom
LEO Pharma

Terminated

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Liver Neoplasms

Canada, France, Italy, Spain, United Kingdom
Sheba Medical Center

Unknown

Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva

Squamous Cell Carcinoma

Israel
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Unknown

Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients (Estimabl)

Thyroid Cancer

France
Hadassah Medical Organization

Unknown

Computer Assisted Early Detection of Liver Metastases From fMRI Maps

Metastatic Colorectal Cancer

Israel
Heidelberg University
Dietmar Hopp Stiftung; Prof. Wolfgang Stremmel

Completed

Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis

Ulcerative Colitis

Germany
Women and Infants Hospital of Rhode Island

Terminated

Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.

Breast Cancer | Ovarian Cancer

United States
ProteoSys AG
Charite University, Berlin, Germany; Medical University Innsbruck; University... and other collaborators

Unknown

Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma

Benign Prostatic Hyperplasia | Prostate Cancer | Prostatic Intraepithelial Neoplasia
National Cancer Center, Korea

Unknown

VATS Lobectomy for Clinical Stage IB or II Lung Cancer

Carcinoma, Non-Small-Cell Lung | Thoracic Surgery, Video-Assisted

Korea, Republic of
Eli Lilly and Company

Completed

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Depression, Bipolar

United States, Puerto Rico
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

Gastrointestinal Neoplasms

Korea, Republic of
Eli Lilly and Company

Completed

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Carcinoma, Small Cell

United States
Eli Lilly and Company

Completed

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

Advanced Gastric Carcinoma

Italy
Eli Lilly and Company

Completed

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung

China, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
Eli Lilly and Company

Completed

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Memorial Sloan Kettering Cancer Center

Completed

Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Eli Lilly and Company

Completed

Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

Argentina, Brazil, Chile, Mexico
Eli Lilly and Company

Completed

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Adenocarcinoma

Canada
Eli Lilly and Company
Aventis Pharmaceuticals

Completed

A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Italy
Eli Lilly and Company

Completed

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Celgene Corporation
Prologue Research International

Completed

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Celgene Corporation

Completed

Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)

Prostate Cancer

United States
National Taiwan University Hospital

Unknown

The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients

Ovarian Cancer

Taiwan
Corixa Corporation

Unknown

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Ludwig-Maximilians - University of Munich

Unknown

Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma

Melanoma | Radiotherapy | Metastatic Disease

Germany
Amsterdam UMC, location VUmc
GlaxoSmithKline; The Netherlands Cancer Institute

Completed

Randomized Trial of Fluticasone in Bronchial Premalignancy

Bronchogenic Carcinoma

Netherlands
National Institute of Cancerología
National Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.

Completed

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Cervical Cancer

Mexico
AGO Study Group

Completed

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer
AGO Study Group

Completed

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Pfizer

Completed

PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients

Carcinoma, Non-Small Cell Lung

United States, Canada
National Institute of Cancerología
National Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.

Terminated

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

Locally Advanced Breast Cancer

Mexico
Charite University, Berlin, Germany
Bristol-Myers Squibb; Pierre Fabre Pharma GmbH

Unknown

Study for Patients With Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Germany
Trial Form Support S.L.
Merck KGaA, Darmstadt, Germany

Unknown

Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

Oropharyngeal Neoplasms

Spain
University of Trieste

Unknown

Avastin for CNV Secondary to Pattern Dystrophy

Choroidal Neovascularization Secondary to Pattern Dystrophy

Italy
Braintree Laboratories

Completed

An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Colonoscopy

United States
University Hospital Freiburg
Novartis; German Federal Ministry of Education and Research; Deutsche Krebshilfe...

Completed

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Germany
GammaCan

Unknown

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Malignant Melanoma | Urologic Cancer | Cancer of Colon

Israel
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Epithelial Ovarian Carcinoma | Figo Stage IIIC

France
AGO Study Group

Completed

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Association of Urologic Oncology (AUO)
Eli Lilly and Company

Unknown

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer

Germany
Austrian Breast & Colorectal Cancer Study Group
Pharmacia Austria GmbH

Completed

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

Breast Cancer

Austria
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Eli Lilly and Company

Terminated

Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer

Ovarian Cancer | Peritoneal Cancer

United States
Weill Medical College of Cornell University

Terminated

Weekly Topotecan Therapy in Patients With Ovarian Cancer

Ovarian Cancer

United States
Sanofi

Completed

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Colorectal Neoplasms | Colorectal Carcinoma | Metastases
Hamilton Health Sciences Corporation
Eli Lilly and Company

Completed

Olanzapine in the Treatment of Hair Pulling (Trichotillomania)

Trichotillomania

Canada

Search clinical trials for: neuroendocrine carcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations